Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
08/18/2023 | KalVista Pharmaceuticals, Inc. | KALV | Sale | Common Stock | 14.9k | $10.73 | $159.6k | | 08/17/2023 |
08/17/2023 | KalVista Pharmaceuticals, Inc. | KALV | Exercise | Restricted Stock Unit | 6.9k | $0.00 | $0 | | 08/17/2023 |
08/17/2023 | KalVista Pharmaceuticals, Inc. | KALV | Exercise | Restricted Stock Unit | 5.8k | $0.00 | $0 | | 08/17/2023 |
08/17/2023 | KalVista Pharmaceuticals, Inc. | KALV | Exercise | Performance Stock Unit | 20.8k | $0.00 | $0 | | 08/17/2023 |
05/18/2023 | KalVista Pharmaceuticals, Inc. | KALV | Sale | Common Stock | 5.6k | $10.14 | $57.1k | | 01/11/2023 |
05/17/2023 | KalVista Pharmaceuticals, Inc. | KALV | Exercise | Restricted Stock Unit | 6.9k | $0.00 | $0 | | 01/11/2023 |
05/17/2023 | KalVista Pharmaceuticals, Inc. | KALV | Exercise | Restricted Stock Unit | 5.8k | $0.00 | $0 | | 01/11/2023 |
02/17/2023 | KalVista Pharmaceuticals, Inc. | KALV | Exercise | | 6.9k | $0.00 | $0 | | 02/17/2023 |
02/17/2023 | KalVista Pharmaceuticals, Inc. | KALV | Sale | Common Stock | 6.7k | $7.66 | $51.3k | | 02/17/2023 |
02/17/2023 | KalVista Pharmaceuticals, Inc. | KALV | Exercise | Performance Restricted Stock Unit | 6.9k | $0.00 | $0 | | 02/17/2023 |
02/17/2023 | KalVista Pharmaceuticals, Inc. | KALV | Exercise | Restricted Stock Unit | 5.8k | $0.00 | $0 | | 02/17/2023 |
01/11/2023 | KalVista Pharmaceuticals, Inc. | KALV | Grant | Restricted Stock Unit | 83.3k | $0.00 | $0 | | 01/11/2023 |
11/18/2022 | KalVista Pharmaceuticals, Inc. | KALV | Sale | Common Stock | 1.8k | $5.44 | $9.7k | | 11/17/2022 |
11/17/2022 | KalVista Pharmaceuticals, Inc. | KALV | Exercise | Restricted Stock Unit | 5.8k | $0.00 | $0 | | 11/17/2022 |
09/02/2022 | KalVista Pharmaceuticals, Inc. | KALV | Sale | Common Stock | 1.3k | $17.01 | $22.5k | | 09/02/2022 |
08/17/2022 | KalVista Pharmaceuticals, Inc. | KALV | Sale | Common Stock | 1.8k | $14.96 | $26.9k | | 08/17/2022 |
08/17/2022 | KalVista Pharmaceuticals, Inc. | KALV | Exercise | Restricted Stock Unit | 5.8k | $0.00 | $0 | | 08/17/2022 |
07/02/2022 | KalVista Pharmaceuticals, Inc. | KALV | Gift | Common Stock | 6.5k | $0.00 | $0 | | 09/02/2022 |
03/09/2022 | KalVista Pharmaceuticals, Inc. | KALV | Sale | Common Stock | 10k | $17.07 | $170.7k | | 03/09/2022 |
10/01/2021 | KalVista Pharmaceuticals, Inc. | KALV | Sale | Common Stock | 10k | $17.18 | $171.8k | | 10/01/2021 |
07/01/2021 | KalVista Pharmaceuticals, Inc. | KALV | Sale | Common Stock | 4.4k | $23.88 | $103.9k | | 07/01/2021 |
07/01/2021 | KalVista Pharmaceuticals, Inc. | KALV | Sale | Common Stock | 5.6k | $24.35 | $137.6k | | 07/01/2021 |
06/17/2021 | KalVista Pharmaceuticals, Inc. | KALV | Sale | Common Stock | 1.1k | $30.04 | $32.1k | | 06/17/2021 |
06/09/2021 | KalVista Pharmaceuticals, Inc. | KALV | Sale | Common Stock | 8.9k | $30.05 | $268.5k | | 06/09/2021 |
05/26/2021 | KalVista Pharmaceuticals, Inc. | KALV | Grant | Employee Stock Option (Right to Buy) | 200k | $25.95 | $5.2M | | 05/26/2021 |
04/29/2021 | KalVista Pharmaceuticals, Inc. | KALV | Gift | Common Stock | 4.8k | $0.00 | $0 | | 05/26/2021 |
04/01/2021 | KalVista Pharmaceuticals, Inc. | KALV | Sale | Common Stock | 700 | $26.22 | $18.4k | | 04/01/2021 |
04/01/2021 | KalVista Pharmaceuticals, Inc. | KALV | Sale | Common Stock | 8.5k | $27.48 | $233.6k | | 04/01/2021 |
04/01/2021 | KalVista Pharmaceuticals, Inc. | KALV | Sale | Common Stock | 800 | $28.11 | $22.5k | | 04/01/2021 |
02/23/2021 | KalVista Pharmaceuticals, Inc. | KALV | Sale | Common Stock | 500 | $35.40 | $17.7k | | 02/23/2021 |
02/23/2021 | KalVista Pharmaceuticals, Inc. | KALV | Sale | Common Stock | 707 | $31.87 | $22.5k | | 02/23/2021 |
02/23/2021 | KalVista Pharmaceuticals, Inc. | KALV | Sale | Common Stock | 1.6k | $32.94 | $51.9k | | 02/23/2021 |
02/23/2021 | KalVista Pharmaceuticals, Inc. | KALV | Sale | Common Stock | 7.2k | $33.73 | $243.4k | | 02/23/2021 |
02/07/2021 | KalVista Pharmaceuticals, Inc. | KALV | Grant | Stock Option (right to buy) | 75k | $24.23 | $1.8M | | 02/07/2021 |
02/07/2021 | KalVista Pharmaceuticals, Inc. | KALV | Grant | Stock Option (right to buy) | 40k | $10.20 | $408k | | 02/07/2021 |
|